From: Epstein-Barr virus infection associated polymyositis and coronary artery dilation
Clinical variables | Values | References |
---|---|---|
IgG (g/L) | 20.8 | 6.36–14.04 |
IgG1 (g/L) | 24.8 | 4.9–11.4 |
IgG2 (g/L) | 1.87 | 1.5–6.4 |
IgG3 (g/L) | 0.99 | 0.2–1.1 |
IgG4 (g/L) | 0.01 | 0.08–1.4 |
IgM (g/L) | 2.49 | 0.29–1.21 |
IgA (g/L) | 1.98 | 0.63–1.79 |
IgE (U/L) | 4.3 | < 100 |
CD 20 (%) | 4.91 | 14–21 |
CD3 (%) | 73.46 | 64–72.5 |
CD4 (%) | 32.06 | 29.5–35.5 |
CD8 (%) | 37.58 | 24–33.5 |
CD3–CD16 + CD56+ (%) | 12.99 | 11–23 |
CD4/CD8 | 0.85 | 0.9–1.4 |
ANA | < 1:80 | < 1:80 |
RF (U/ml) | 255 | 0–14 |
EBVEA–IgG | + | – |
EBVCA–IgG | > 750 U/mL | – |
EBVCA–IgM | − | – |
EBVNA–IgG | > 600 U/mL | – |
CMV IgM | − | – |
EBV DNA (copies/mL) | − | – |
Plasma (day 7) | 1.09 × 104 | < 5.0 × 102 |
Plasma (day 23) | 6.96 × 103 | < 5.0 × 102 |
Plasma (day 39) | 9.55 × 102 | < 5.0 × 102 |
Plasma (day 55) | 1.22 × 103 | < 5.0 × 102 |
B cells (day 7, copies/106 cells) | 1.37 × 104 | < 5.0 × 102 |
T cells (day 7, copies/106 cells) | 9.02 × 105 | < 5.0 × 102 |
NK cells (day 7, copies/106 cells) | 1.64 × 104 | < 5.0 × 102 |
Mitochondrial gene testing | No significant pathogenic gene mutations | – |
Whole exome testing | No significant pathogenic gene mutations | – |